We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Brookdale Senior Living
BKD
$3.62B
| $246K | ﹤0.01% |
36,170
+11,194
| +45% | +$79.9K |
|
1602
PVH
PVH
$3.71B
| $246K | ﹤0.01% |
2,435
-2,905
| -54% | -$289K |
|
1603
Goldman Sachs BDC
GSBD
$975M
| $245K | ﹤0.01% |
17,827
+714
| +4% | +$10.4K |
|
|
TELL
1604
DELISTED
Tellurian Inc.
TELL
| $245K | ﹤0.01% |
252,950
+174,618
| +223% | +$151K |
|
1605
Scansource
SCSC
$1.12B
| $244K | ﹤0.01% |
+5,085
| New | +$241K |
|
|
VISN
1606
Vistance Networks Inc
VISN
$2.66B
| $244K | ﹤0.01% |
39,888
+11,827
| +42% | +$40.5K |
|
1607
MDU Resources
MDU
$4.44B
| $244K | ﹤0.01% |
16,043
-1,312
| -8% | -$18.7K |
|
|
AIV
1608
Aimco
AIV
$380M
| $243K | ﹤0.01% |
26,881
+7,554
| +39% | +$67.2K |
|
1609
Maravai LifeSciences
MRVI
$997M
| $243K | ﹤0.01% |
+29,237
| New | +$253K |
|
|
HCP
1610
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $242K | ﹤0.01% |
7,161
-279
| -4% | -$9.41K |
|
1611
Brunswick
BC
$5.19B
| $242K | ﹤0.01% |
2,887
-300
| -9% | -$23.3K |
|
1612
Kaiser Aluminum
KALU
$2.67B
| $242K | ﹤0.01% |
3,332
-84,640
| -96% | -$6.51M |
|
1613
Arlo Technologies
ARLO
$1.4B
| $242K | ﹤0.01% |
19,949
+6,007
| +43% | +$79.5K |
|
1614
Stagwell
STGW
$1.84B
| $241K | ﹤0.01% |
34,378
+6,049
| +21% | +$41.4K |
|
1615
Enliven Therapeutics
ELVN
$3.78B
| $241K | ﹤0.01% |
+9,441
| New | +$219K |
|
|
CIM
1616
Chimera Investment
CIM
$1.05B
| $241K | ﹤0.01% |
15,223
+5,059
| +50% | +$75.8K |
|
|
UMH
1617
UMH Properties
UMH
$1.32B
| $241K | ﹤0.01% |
12,248
-4,072
| -25% | -$75.8K |
|
|
BBT
1618
Beacon Financial Corp
BBT
$2.53B
| $241K | ﹤0.01% |
+8,943
| New | +$234K |
|
1619
Nicolet Bankshares
NIC
$3.57B
| $240K | ﹤0.01% |
+2,513
| New | +$235K |
|
1620
MaxLinear
MXL
$6.49B
| $240K | ﹤0.01% |
16,587
+4,884
| +42% | +$77.5K |
|
|
ADAM
1621
Adamas Trust
ADAM
$777M
| $240K | ﹤0.01% |
37,856
+23,838
| +170% | +$153K |
|
1622
AdaptHealth
AHCO
$1.46B
| $239K | ﹤0.01% |
21,316
+6,935
| +48% | +$73.7K |
|
1623
Idacorp
IDA
$8.23B
| $239K | ﹤0.01% |
2,322
-69
| -3% | -$6.89K |
|
1624
Dentsply Sirona
XRAY
$2.59B
| $239K | ﹤0.01% |
8,837
-955
| -10% | -$24.4K |
|
1625
Post Holdings
POST
$4.12B
| $239K | ﹤0.01% |
2,063
-309
| -13% | -$34.6K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.